{"entity":{"id":"nct02213991","kind":"trial","name":"Intraoperative Radiotherapy for Korean Patients With Breast Cancer","aka":[],"tldr":"A phase 2 trial of Intraoperative radiotherapy in Breast cancer, run by Gangnam Severance Hospital, with a status the registry has not verified recently.","summary":"Intraoperative Radiotherapy for Korean Patients With Breast Cancer is a phase 2 interventional study registered as NCT02213991 by Gangnam Severance Hospital, with 215 participants planned, started 2014-08 and due to reach its primary completion in 2017-10. Interventions recorded: Intraoperative radiotherapy using Intrabeam®. Conditions recorded: Breast Cancer.\n\nLinked to the technology Intraoperative radiotherapy because the registry names it (\"intraoperative radiotherapy\") among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT02213991","url":"https://clinicaltrials.gov/study/NCT02213991"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["breast-cancer"],"sections":[],"technologies":["intraoperative-radiotherapy"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02213991","phase":"2","setting":"A Phase II Trial Investigating Acute Local Toxicities of Intraoperative Radiotherapy as a Boost Dose in Korean Breast Cancer Patients Undergoing Breast Conserving Surgery","sponsor":"Gangnam Severance Hospital","enrolled":215,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02213991/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"}],"technology":[{"id":"intraoperative-radiotherapy","kind":"technology","name":"Intraoperative radiotherapy (IORT)","route":"/technologies/intraoperative-radiotherapy/"}]}}